1.Gene Expression of Endothelin-1 and Endothelin Receptor A on Monocrotaline-Induced Pulmonary Hypertension in Rats After Bosentan Treatment.
Kyoung Ah LIM ; Kwan Chang KIM ; Min Sun CHO ; Bo En LEE ; Hae Soon KIM ; Young Mi HONG
Korean Circulation Journal 2010;40(9):459-464
BACKGROUND AND OBJECTIVES: Endothelin (ET)-1, a potent endothelium-derived vasoconstrictor peptide, has a potential pathophysiologic role in pulmonary hypertension. Bosentan, a dual ET receptor (ET(A)/ET(B)) antagonist, is efficacious in treatment of pulmonary hypertension. The objectives of this study were to investigate the expression of ET-1 and ET receptor A (ERA) genes and to evaluate the effect of bosentan in monocrotaline (MCT)-induced pulmonary hypertension. MATERIALS AND METHODS: Four-week-old male Sprague-Dawley rats were treated as follows: control (n=36), subcutaneous (sc) injection of saline; MCT (n=36), sc injection of MCT (60 mg/kg); and bosentan (n=36), sc injection of MCT (60 mg/kg) plus 25 mg/kg/day bosentan orally. RESULTS: Serum ET-1 concentrations in the MCT group were higher than the control group on day 28 and 42. Quantitative analysis of peripheral pulmonary arteries revealed that the increase in medial wall thickness after MCT injection was significantly attenuated in the bosentan group on day 28 and 42. In addition, the increase in the number of intra-acinar muscular arteries after MCT injection was reduced by bosentan on day 14, 28 and 42. The levels of ET-1 and ERA gene expression were significantly increased in the MCT group compared with control group on day 5, and bosentan decreased the expression of ET-1 on day 5. CONCLUSION: ET-1 contributes to the progression of cardiopulmonary pathology in rats with MCT-induced pulmonary hypertension. Administration of bosentan reduced ET-1 gene expression in MCT-induced pulmonary hypertension in rats.
Animals
;
Arteries
;
Endothelin-1
;
Endothelins
;
Gene Expression
;
Humans
;
Hypertension, Pulmonary
;
Male
;
Monocrotaline
;
Pulmonary Artery
;
Rats
;
Rats, Sprague-Dawley
;
Receptors, Endothelin
;
Sulfonamides
2.Murine Model of Buckwheat Allergy by Intragastric Sensitization with Fresh Buckwheat Flour Extract.
Soo Young LEE ; Sejo OH ; Kisun LEE ; Young Ju JANG ; Myung Hyun SOHN ; Kyoung En LEE ; Kyu Earn KIM
Journal of Korean Medical Science 2005;20(4):566-572
Food allergies affect about 4% of the Korean population, and buckwheat allergy is one of the most severe food allergies in Korea. The purpose of the present study was to develop a murine model of IgE-mediated buckwheat hypersensitivity induced by intragastric sensitization. Young female C3H/HeJ mice were sensitized and challenged intragastricly with fresh buckwheat flour (1, 5, 25 mg/dose of proteins) mixed in cholera toxin, followed by intragastric challenge. Anaphylactic reactions, antigen-specific antibodies, splenocytes proliferation assays and cytokine productions were evaluated. Oral buckwheat challenges of sensitized mice provoked anaphylactic reactions such as severe scratch, perioral/periorbital swellings, or decreased activity. Reactions were associated with elevated levels of buckwheatspecific IgE antibodies. Splenocytes from buckwheat allergic mice exhibited significantly greater proliferative responses to buckwheat than non-allergic mice. Buckwheat-stimulated IL-4, IL-5, and INF-gamma productions were associated with elevated levels of buckwheat-specific IgE in sensitized mice. In this model, 1 mg and 5 mg dose of sensitization produced almost the same degree of Th2-directed immune response, however, a 25 mg dose showed blunted antibody responses. In conclusion, we developed IgE-mediated buckwheat allergy by intragastric sensitization and challenge, and this model could provide a good tool for future studies.
Anaphylaxis/blood/immunology
;
Animals
;
Cell Proliferation/drug effects
;
Comparative Study
;
Disease Models, Animal
;
Dose-Response Relationship, Drug
;
Enzyme-Linked Immunosorbent Assay
;
Fagopyrum/*immunology
;
Female
;
*Flour
;
Food Hypersensitivity/blood/*immunology
;
Immunoglobulin E/blood/immunology
;
Immunoglobulin G/blood/immunology
;
Interferon Type II/biosynthesis
;
Interleukin-4/biosynthesis
;
Interleukin-5/biosynthesis
;
Mice
;
Mice, Inbred C3H
;
Plant Extracts/administration & dosage/immunology
;
Research Support, Non-U.S. Gov't
;
Spleen/cytology/drug effects/metabolism
;
Stomach/drug effects/*immunology
;
T-Lymphocytes/cytology/drug effects/metabolism
;
Time Factors
3.Troubleshooting Arterial-Phase MR Images of Gadoxetate Disodium-Enhanced Liver.
Jimi HUH ; So Yeon KIM ; Benjamin M YEH ; Seung Soo LEE ; Kyoung Won KIM ; En Haw WU ; Z Jane WANG ; Li Qin ZHAO ; Wei Chou CHANG
Korean Journal of Radiology 2015;16(6):1207-1215
Gadoxetate disodium is a widely used magnetic resonance (MR) contrast agent for liver MR imaging, and it provides both dynamic and hepatobiliary phase images. However, acquiring optimal arterial phase images at liver MR using gadoxetate disodium is more challenging than using conventional extracellular MR contrast agent because of the small volume administered, the gadolinium content of the agent, and the common occurrence of transient severe motion. In this article, we identify the challenges in obtaining high-quality arterial-phase images of gadoxetate disodium-enhanced liver MR imaging and present strategies for optimizing arterial-phase imaging based on the thorough review of recent research in this field.
Angiography
;
Arteries/anatomy & histology
;
Contrast Media/*chemistry
;
Gadolinium DTPA/*chemistry
;
Humans
;
Liver/*radiography
;
*Magnetic Resonance Imaging